IP Library › Granted Patent US 12,628,861
Granted Patent B2
US 12,628,861 · App. 18/303,293 · Granted May 19, 2026

Liquid formulations for oral flavored product

Inventors: John Morrison (Louisville, KY); Brendan McDermott (Santa Monica, CA); Trent Grantz (Louisville, KY); Rob Riesel (Louisville, KY)
Assignee: INTREPID BRANDS, LLC
A24B15/167
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,628,861
App. No.
18/303,293
Granted
May 19, 2026
Kind
B2
Abstract

Liquid formulations for use in an oral product include about 85% w/w to about 95% w/w of a carrier liquid; about 1% w/w to about 5% w/w of a flavoring agent; about 1% w/w to about 2% w/w of an active ingredient; and about 0.5% w/w to about 3.5% w/w of a sweetener. Oral products are further provided and comprise about 25% w/w to about 30% w/w of a fibrous substrate; about 50% w/w to about 70% w/w of a carrier liquid; about 1% w/w to about 5% w/w of a flavoring agent; about 0.5% w/w to about 2% w/w of an active ingredient; and about 0.1% w/w to about 3.5% w/w of a sweetener. Methods of making an oral product are also provided and comprise the steps of providing an exemplary liquid formulation, and then combining the liquid formulation with a fibrous substrate.

Claims (51)

1 . A liquid formulation for use in an oral product, comprising:

about 85% w/w to about 95% w/w of a carrier liquid;

about 1% w/w to about 5% w/w of a flavoring agent;

about 1% w/w to about 2% w/w of an active ingredient; and

about 0.5% w/w to about 3.5% w/w of a sweetener,

wherein the carrier liquid comprises about 30% w/w to about 50% w/w of propylene glycol, about 15% w/w to about 30% w/w of glycerin, and about 5% w/w to about 10% w/w water.

2 . The liquid formulation of claim 1 , wherein the glycerin is vegetable glycerin.

3 . The liquid formulation of claim 1 , wherein the active ingredient comprises nicotine.

4 . The liquid formulation of claim 1 , further comprising about 1% w/w to about 6% w/w of a binding agent.

5 . The liquid formulation of claim 1 , and wherein the sweetener comprises sucralose or saccharine.

6 . An oral product, comprising:

about 25% w/w to about 30% w/w of a fibrous substrate;

about 50% w/w to about 70% w/w of a carrier liquid;

about 1% w/w to about 5% w/w of a flavoring agent;

about 0.5% w/w to about 2% w/w of an active ingredient; and

about 0.1% w/w to about 3.5% w/w of a sweetener,

wherein the carrier liquid comprises about 30% w/w to about 50% w/w of propylene glycol, about 15% w/w to about 30% w/w of glycerin, and about 5% w/w to about 10% w/w water.

7 . The oral product of claim 6 , wherein the active ingredient comprises nicotine.

8 . The oral product of claim 7 , wherein the nicotine is included in the formulation in an amount of about 0.5% w/w to about 1% w/w.

9 . The oral product of claim 6 , further comprising about 0.5% w/w to about 6% w/w of a binding agent.

10 . The oral product of claim 6 , and wherein the sweetener comprises sucralose or saccharine.

11 . The oral product of claim 6 , wherein the fibrous substrate is comprised of a synthetic polymer.

12 . The oral product of claim 11 , wherein the synthetic polymer is polyester.

13 . The oral product of claim 6 , wherein the oral product comprises:

about 36% w/w propylene glycol;

about 27% w/w of a polyester fibrous substrate;

about 27% w/w vegetable glycerin;

about 7% w/w water;

about 1% w/w to about 2% w/w of a flavoring agent;

about 1% w/w triacetin;

about 1% w/w nicotine; and

about 0.5% sucralose.

14 . The oral product of claim 6 , wherein the oral product comprises:

about 34% w/w propylene glycol;

about 27% w/w of a polyester fibrous substrate;

about 27% w/w vegetable glycerin;

about 7% w/w water;

about 1% w/w to about 2% w/w of a flavoring agent;

about 2% w/w sorbitol;

about 1% w/w nicotine; and

about 0.5% saccharine.

15 . A method of making an oral product, comprising:

providing a liquid formulation including

about 85% w/w to about 95% w/w of a carrier liquid,

about 1% w/w to about 5% w/w of a flavoring agent,

about 1% w/w to about 2% w/w of an active ingredient, and

about 0.5% w/w to about 3.5% w/w of a sweetener; and

combining the liquid formulation with a fibrous substrate,

wherein the carrier liquid comprises about 30% w/w to about 50% w/w of propylene glycol, about 15% w/w to about 30% w/w of glycerin, and about 5% w/w to about 10% w/w water.

16 . The method of claim 15 , wherein combining the liquid formulation with the fibrous substrate comprises sorbing the liquid formulation onto the fibrous substrate.

17 . The method of claim 15 , wherein the liquid formulation further includes about 1% w/w to about 6% w/w of a binding agent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2024
From: MORRISON, JOHN; GRANTZ, TRENT; RIESEL, ROB
To: INTREPID BRANDS, LLC
Reel/Frame 067091/0883 →
Continuity (2)
Provisional Application 63332496 · Apr 19, 2022
Related Publication 20230329318A1 · Oct 19, 2023
References Cited (13)
US 9185931B2 · Gao et al. · 2015 [cited by applicant]
US 9420827B2 · Mishra et al. · 2016 [cited by applicant]
US 9521864B2 · Gao et al. · 2016 [cited by applicant]
US 10183016B2 · Gao et al. · 2019 [cited by applicant]
US 10349672B2 · Gao et al. · 2019 [cited by applicant]
US 20050260264A1 · Edgren et al. · 2005 [cited by applicant]
US 20140332013A1 · Gao · 2014 [cited by examiner]
US 20160354360A1 · Gao et al. · 2016 [cited by applicant]
US 20200246404A1 · Yucel · 2020 [cited by examiner]
US 20210169788A1 · Mua et al. · 2021 [cited by applicant]
US 20210251277A1 · McDermott et al. · 2021 [cited by applicant]
What Is Vegetable Glycerin? Uses, Benefits and Side Effects, 2023, healthlijne, [online], retrieved from the Internet, [retrieved Aug. 27, 2025], URL:https://www.healthline.com/nutrition/vegetable-glycerin. (Year: 2023). [cited by examiner]
United States Patent and Trademark Office, International Search Report and Written Opinion issued in corresponding Application No. PCT/US2023/065953, mailed Sep. 1, 2023. [cited by applicant]